Group B streptococcal infection medical therapy: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 16: | Line 16: | ||
|- | |- | ||
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1-23 months ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |[[Streptococcus pneumoniae]] <br> [[Neisseria meningitidis]] <br> [[Streptococcus agalactiae]] <br> [[Haemophilus influenzae]] <br> [[E. coli]]|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |[[Vancomycin]] + third generation [[cephalosporin]] | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1-23 months ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |[[Streptococcus pneumoniae]] <br> [[Neisseria meningitidis]] <br> [[Streptococcus agalactiae]] <br> [[Haemophilus influenzae]] <br> [[E. coli]]|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |[[Vancomycin]] + third generation [[cephalosporin]] | ||
|- | |||
|} | |||
===Targeted Antibiotic Therapy in Neonatal Meningitis=== | |||
{| style="cellpadding=0; cellspacing= 0; width: 800px;" | |||
|- | |||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align=center | '''Recommended therapy for GBS meningitis'''|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align=center | '''Alternative therapy for GBS meningitis''' | |||
|- | |||
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[Ampicillin]] <br> OR<br> [[Penicillin]] <br> ''Consider adding an [[aminoglycoside]]''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Third generation cephalosporin <br> ([[Ceftriaxone]] or [[cefotaxime]]) | |||
|- | |- | ||
|} | |} | ||
Revision as of 21:33, 19 August 2014
|
Group B Streptococcal Infection Microchapters |
|
Differentiating Group B Streptococcal Infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Group B streptococcal infection medical therapy On the Web |
|
American Roentgen Ray Society Images of Group B streptococcal infection medical therapy |
|
Directions to Hospitals Treating Group B streptococcal infection |
|
Risk calculators and risk factors for Group B streptococcal infection medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
Medical Therapy
Empirical Antibiotic Therapy in Neonatal Meningitis
GBS should be suspected as a causative agent for bacterial meningitis in infants less than two years of age for whom empirical antibiotic therapy should be initiated immediately.
| Age | Possible pathogens causing the bacterial meningitis | Empirical treatment |
| < 1 month | Streptococcus agalactiae Escherichia coli Listeria monocytogenes Klebsiella |
Ampicillin + cefotaxime OR Ampicillin + aminoglycoside |
| 1-23 months | Streptococcus pneumoniae Neisseria meningitidis Streptococcus agalactiae Haemophilus influenzae E. coli |
Vancomycin + third generation cephalosporin |
Targeted Antibiotic Therapy in Neonatal Meningitis
| Recommended therapy for GBS meningitis | Alternative therapy for GBS meningitis |
| Ampicillin OR Penicillin Consider adding an aminoglycoside |
Third generation cephalosporin (Ceftriaxone or cefotaxime) |